SCHEMBL8327199

SCHEMBL8327199

Cc1ccc2nc(-c3ccccc3C(=O)O)cc(C(=O)O)c2c1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.74
ALDH1A1 P00352 5/20 0.74
HSD17B10 Q99714 2/20 0.74
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
DHODH Q02127 4/20 0.54
MAPK1 P28482 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
LMNA P02545 2/20 0.54
TP53 P04637 1/20 0.54
MAPT P10636 3/20 0.53
HPGD P15428 2/20 0.52
USP2 O75604 1/20 0.52
TSHR P16473 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
PDE10A Q9Y233 1/20 0.50
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8321360 0.96 KDM4E (0.69) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL8687997 0.90 KDM4E (0.64) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL1898810 0.85 KDM4E (1.00) KDM4EALDH1A1HSD17B10DHODHMAPK1
SCHEMBL8717010 0.84 KDM4E (0.54) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL8326754 0.84 KDM4E (0.59) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL8324531 0.83 MEN1 (0.77) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL8322442 0.83 KDM4E (0.55) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL8618627 0.82 ALDH1A1 (0.65) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL8321362 0.81 KDM4E (0.51) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL8329204 0.81 KDM4E (0.63) KDM4EALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709377-B1 Process for producing quinolin-2-yl benzoic acid compounds ASAHI GLASS CO LTD (JP) 1999-09-29 EP claimed
EP-0693478-B1 Quinoline compounds GREEN CROSS CORP (JP) 1998-08-12 EP claimed
US-5780634-A Process for producing 2-(carboxyphenyl)-4-quinolinecarboxylic acid compounds THE GREEN CROSS CORPORATION (JP) 1998-07-14 US claimed
US-5665881-A CARDIOVASCULAR DISORDERS, HYPOTENSIVE, ANGIOTENSIN II ANTAGONIST THE GREEN CROSS CORPORATION (JP) 1997-09-09 US claimed
EP-0709377-A1 Process for producing quinolin-2-yl benzoic acid compounds ASAHI GLASS COMPANY LTD. (JP) 1996-05-01 EP claimed
EP-0693478-A1 Quinoline compounds THE GREEN CROSS CORPORATION (JP) 1996-01-24 EP claimed
JP-8119941-A None JP disclosed
JP-6016641-A None JP disclosed
EP-0709377-B1 Process for producing quinolin-2-yl benzoic acid compounds ASAHI GLASS CO LTD (JP) 1999-09-29 EP disclosed
EP-0693478-B1 Quinoline compounds GREEN CROSS CORP (JP) 1998-08-12 EP disclosed
US-5780634-A Process for producing 2-(carboxyphenyl)-4-quinolinecarboxylic acid compounds THE GREEN CROSS CORPORATION (JP) 1998-07-14 US disclosed
US-5665881-A CARDIOVASCULAR DISORDERS, HYPOTENSIVE, ANGIOTENSIN II ANTAGONIST THE GREEN CROSS CORPORATION (JP) 1997-09-09 US disclosed
EP-0569013-B1 Quinoline compounds as angiotensin II antagonists GREEN CROSS CORP (JP) 1996-08-28 EP disclosed
JP-H08119941-A PRODUCTION OF QUINOLINE-2-YLBENZOIC ACIDS ASAHI GLASS CO LTD 1996-05-14 JP disclosed
EP-0709377-A1 Process for producing quinolin-2-yl benzoic acid compounds ASAHI GLASS COMPANY LTD. (JP) 1996-05-01 EP disclosed
EP-0693478-A1 Quinoline compounds THE GREEN CROSS CORPORATION (JP) 1996-01-24 EP disclosed
US-5478832-A Angiotensin II antagonists; cardiovascular disorders THE GREEN CROSS CORPORATION (JP) 1995-12-26 US disclosed
JP-H0616641-A QUINOLIN-2-YLBENZOIC ACID DERIVATIVE AND ITS PRODUCTION ASAHI GLASS CO LTD 1994-01-25 JP disclosed
EP-0569013-A1 Quinoline compounds as angiotensin II antagonists THE GREEN CROSS CORPORATION (JP) 1993-11-10 EP disclosed